Type 2 diabetes trials in South Africa
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Brackenfell, Cape Town, Claremont, Durban, eMkhomazi, Johannesburg, KwaDukuza, Paarl, Pretoria
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Benoni, Bloemfontein, Cape Town, Centurion, Century City, Durban, Gauteng, Johannesburg, Pietermaritzburg, Pretoria, Raslouw, Somerset West, Soweto, Tygervalley, Worcester, Wynberg
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bellville, Bloemfontein, Cape Town, Chatsworth, Claremont, Durban, eMkhomazi, Johannesburg, Midrand, Wentworth
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- Where
- Bloemfontein, Cape Town, East London, eMkhomazi, Johannesburg, Kimberley, Krugersdorp, Lenasia, Paarl, Pretoria, Somerset West
- Age
- 18 years to 65 years
- People
- 130 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07613307 - Phase 3Taking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Bloemfontein, Cape Town, Durban, Johannesburg, Lenasia, Mossel Bay, Paarl, Cape Town, Port Elizabeth, Pretoria, Somerset West
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Florida, Parow, Umhlanga
- Age
- 18 years and over
- People
- 35,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Brackenfell, Cape Town, Claremont, Durban, eMkhomazi, Johannesburg, KwaDukuza, Paarl, Pretoria
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00